190 related articles for article (PubMed ID: 26692285)
1. Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.
Gose T; Nakanishi T; Kamo S; Shimada H; Otake K; Tamai I
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():10-7. PubMed ID: 26692285
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin Transporter OATP2A1/
Nakamura Y; Nakanishi T; Shimada H; Shimizu J; Aotani R; Maruyama S; Higuchi K; Okura T; Deguchi Y; Tamai I
J Neurosci; 2018 Jun; 38(24):5584-5595. PubMed ID: 29899035
[TBL] [Abstract][Full Text] [Related]
3. OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion.
Shimada H; Nakamura Y; Nakanishi T; Tamai I
Biochem Pharmacol; 2015 Dec; 98(4):629-38. PubMed ID: 26474801
[TBL] [Abstract][Full Text] [Related]
4. Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1.
Kamo S; Nakanishi T; Aotani R; Nakamura Y; Gose T; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2483-2490. PubMed ID: 28479361
[TBL] [Abstract][Full Text] [Related]
5. A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer.
Nakanishi T; Ohno Y; Aotani R; Maruyama S; Shimada H; Kamo S; Oshima H; Oshima M; Schuetz JD; Tamai I
Sci Rep; 2017 Nov; 7(1):16567. PubMed ID: 29185482
[TBL] [Abstract][Full Text] [Related]
6. Phenolsulfonphthalein as a surrogate substrate to assess altered function of the prostaglandin transporter SLCO2A1.
Nakamura Y; Kozakai H; Nishio T; Yoshida K; Nakanishi T
Drug Metab Pharmacokinet; 2022 Jun; 44():100452. PubMed ID: 35299026
[TBL] [Abstract][Full Text] [Related]
7. Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.
Nakanishi T; Tamai I
AAPS J; 2017 Dec; 20(1):13. PubMed ID: 29204966
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the prostaglandin transporter OATP2A1 and prostaglandin E2-mediated cellular effects.
Bujok K; Glaeser H; Schuh W; Rau TT; Schmidt I; Fromm MF; Mandery K
Cell Signal; 2015 Mar; 27(3):663-72. PubMed ID: 25433165
[TBL] [Abstract][Full Text] [Related]
9. Experimental Evidence for Resecretion of PGE
Nakanishi T; Takashima H; Uetoko Y; Komori H; Tamai I
J Pharmacol Exp Ther; 2019 Feb; 368(2):317-325. PubMed ID: 30420359
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
[TBL] [Abstract][Full Text] [Related]
11. Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation.
Nakanishi T; Sakiyama S; Takashima H; Honda R; Shumba MN; Nakamura Y; Kasahara K; Tamai I
Toxicol Appl Pharmacol; 2020 Oct; 405():115201. PubMed ID: 32828905
[TBL] [Abstract][Full Text] [Related]
12. The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost.
Kraft ME; Glaeser H; Mandery K; König J; Auge D; Fromm MF; Schlötzer-Schrehardt U; Welge-Lüssen U; Kruse FE; Zolk O
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2504-11. PubMed ID: 20019365
[TBL] [Abstract][Full Text] [Related]
13. Modulation of prostaglandin transport activity of SLCO2A1 by annexin A2 and S100A10.
Nakamura Y; Ito MA; Hoshino Y; Matsuoka I; Okada T; Okada Y; Nakanishi T
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1042-C1053. PubMed ID: 38372137
[TBL] [Abstract][Full Text] [Related]
14. Role of OATP2A1 in PGE(2) secretion from human colorectal cancer cells via exocytosis in response to oxidative stress.
Kasai T; Nakanishi T; Ohno Y; Shimada H; Nakamura Y; Arakawa H; Tamai I
Exp Cell Res; 2016 Feb; 341(2):123-31. PubMed ID: 26850138
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
Yang P; Cartwright C; Chan D; Ding J; Felix E; Pan Y; Pang J; Rhea P; Block K; Fischer SM; Newman RA
Mol Carcinog; 2014 Jul; 53(7):566-77. PubMed ID: 23371504
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation modifies prostaglandin E
Nakamura Y; Aizawa C; Kawata H; Nakanishi T
Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106714. PubMed ID: 36706979
[TBL] [Abstract][Full Text] [Related]
17. Effect of eicosapentaenoic acid-derived prostaglandin E3 on intestinal epithelial barrier function.
Rodríguez-Lagunas MJ; Ferrer R; Moreno JJ
Prostaglandins Leukot Essent Fatty Acids; 2013 May; 88(5):339-45. PubMed ID: 23453388
[TBL] [Abstract][Full Text] [Related]
18. Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.
Taub ME; Mease K; Sane RS; Watson CA; Chen L; Ellens H; Hirakawa B; Reyner EL; Jani M; Lee CA
Drug Metab Dispos; 2011 Nov; 39(11):2093-102. PubMed ID: 21849517
[TBL] [Abstract][Full Text] [Related]
19. Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin.
Glaeser H; Bujok K; Schmidt I; Fromm MF; Mandery K
Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):883-91. PubMed ID: 24947867
[TBL] [Abstract][Full Text] [Related]
20. Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa.
Mandery K; Bujok K; Schmidt I; Wex T; Treiber G; Malfertheiner P; Rau TT; Amann KU; Brune K; Fromm MF; Glaeser H
J Pharmacol Exp Ther; 2010 Feb; 332(2):345-51. PubMed ID: 19843975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]